ACACB and hepatocellular carcinoma: Among the potential regulatory oncomiRs, has-miR-9-5p, 182-5p (targeting ANGPTL1), 19a-3p (targeting SOCS3), 452-3p (targeting ACACB), and 589-3p (targeting EHHADH) exhibited increased expression in HCC cells (Figure 1H and Figure S1).